메뉴 건너뛰기




Volumn 23, Issue 8, 2013, Pages 522-530

Associations among obesity, acute weight gain, and response to treatment with Olanzapine in adolescent schizophrenia

Author keywords

[No Author keywords available]

Indexed keywords

OLANZAPINE; PLACEBO;

EID: 84886057408     PISSN: 10445463     EISSN: 15578992     Source Type: Journal    
DOI: 10.1089/cap.2012.0099     Document Type: Article
Times cited : (36)

References (59)
  • 1
    • 84870469320 scopus 로고    scopus 로고
    • American Psychiatric Association Washington, DC American Psychiatric Association, 4th ed., Text Revision
    • American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed., Text Revision. Washington, DC: American Psychiatric Association; 2000.
    • (2000) Diagnostic and Statistical Manual of Mental Disorders
  • 3
    • 12944295044 scopus 로고    scopus 로고
    • Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia
    • Ascher-Svanum H, Stensland M, Zhao Z, Kinon BJ: Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia. BMC Psychiatry 5:3, 2005a.
    • (2005) BMC Psychiatry , vol.5 , Issue.3
    • Ascher-Svanum, H.1    Stensland, M.2    Zhao, Z.3    Kinon, B.J.4
  • 4
    • 33645471530 scopus 로고    scopus 로고
    • Weight gain as a prognostic indicator of therapeutic improvement during acute treatment of schizophrenia with placebo or active antipsychotic
    • Ascher-Svanum H, Stensland M, Zhao Z, Kinon BJ: Weight gain as a prognostic indicator of therapeutic improvement during acute treatment of schizophrenia with placebo or active antipsychotic. J Psychopharmacol 19 Suppl 6:110-117, 2005b.
    • (2005) J Psychopharmacol , vol.19 , Issue.SUPPL. 6 , pp. 110-117
    • Ascher-Svanum, H.1    Stensland, M.2    Zhao, Z.3    Kinon, B.J.4
  • 5
    • 33746886660 scopus 로고    scopus 로고
    • Association of initial antipsychotic response to clozapine and long-term weight gain
    • Bai YM, Lin CC, Chen JY, Lin CY, Su TP, Chou P: Association of initial antipsychotic response to clozapine and long-term weight gain. Am J Psychiatry 163:1276-1279, 2006.
    • (2006) Am J Psychiatry , vol.163 , pp. 1276-1279
    • Bai, Y.M.1    Lin, C.C.2    Chen, J.Y.3    Lin, C.Y.4    Su, T.P.5    Chou, P.6
  • 6
    • 0035024729 scopus 로고    scopus 로고
    • Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, Haloperidol, or risperidone
    • Basson BR, Kinon BJ, Taylor CC, Szymanski KA, Gilmore JA, Tollefson GD: Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone. J Clin Psychiatry 62:231-238, 2001.
    • (2001) J Clin Psychiatry , vol.62 , pp. 231-238
    • Basson, B.R.1    Kinon, B.J.2    Taylor, C.C.3    Szymanski, K.A.4    Gilmore, J.A.5    Tollefson, G.D.6
  • 7
    • 0029904335 scopus 로고    scopus 로고
    • Differential effect of clozapine on weight: A controlled study
    • Bustillo JR, Buchanan RW, Irish D, Breier A: Differential effect of clozapine on weight: A controlled study. Am J Psychiatry 153:817-819, 1996.
    • (1996) Am J Psychiatry , vol.153 , pp. 817-819
    • Bustillo, J.R.1    Buchanan, R.W.2    Irish, D.3    Breier, A.4
  • 8
    • 46649109792 scopus 로고    scopus 로고
    • Assessing and maximizing the safety and tolerability of antipsychotics used in the treatment of children and adolescents
    • Correll CU: Assessing and maximizing the safety and tolerability of antipsychotics used in the treatment of children and adolescents. J Clin Psychiatry 69 Suppl 4:26-36, 2008.
    • (2008) J Clin Psychiatry , vol.69 , Issue.SUPPL. 4 , pp. 26-36
    • Correll, C.U.1
  • 10
    • 70350738289 scopus 로고    scopus 로고
    • Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents
    • Correll CU, Manu P, Olshanskiy V, Napolitano B, Kane JM, Malhotra AK: Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. JAMA 302:1765-1773, 2009.
    • (2009) JAMA , vol.302 , pp. 1765-1773
    • Correll, C.U.1    Manu, P.2    Olshanskiy, V.3    Napolitano, B.4    Kane, J.M.5    Malhotra, A.K.6
  • 12
    • 84856466929 scopus 로고    scopus 로고
    • Metabolic and cardiovascular adverse effects associated with antipsychotic drugs
    • De Hert M, Detraux J, van Winkel R, Yu W, Correll CU: Metabolic and cardiovascular adverse effects associated with antipsychotic drugs. Nat Rev Endocrinol 8:114-126, 2011.
    • (2011) Nat Rev Endocrinol , vol.8 , pp. 114-126
    • De Hert, M.1    Detraux, J.2    Van Winkel, R.3    Yu, W.4    Correll, C.U.5
  • 13
    • 26444447991 scopus 로고    scopus 로고
    • Metabolic syndrome in bipolar disorder: Findings from the Bipolar Disorder Center for Pennsylvanians
    • Fagiolini A, Frank E, Scott JA, Turkin S, Kupfer DJ: Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians. Bipolar Disord 7:424-430, 2005.
    • (2005) Bipolar Disord , vol.7 , pp. 424-430
    • Fagiolini, A.1    Frank, E.2    Scott, J.A.3    Turkin, S.4    Kupfer, D.J.5
  • 15
    • 84867811761 scopus 로고    scopus 로고
    • Efficacy and safety of quetiapine in adolescents with schizophrenia: A 6-week, double-blind, placebo-controlled trial
    • Findling RL, McKenna K, Earley WR, Stankowski J, Pathak S: Efficacy and safety of quetiapine in adolescents with schizophrenia: a 6-week, double-blind, placebo-controlled trial. J Child Adolesc Psychopharmacol 22:327-342, 2012.
    • (2012) J Child Adolesc Psychopharmacol , vol.22 , pp. 327-342
    • Findling, R.L.1    McKenna, K.2    Earley, W.R.3    Stankowski, J.4    Pathak, S.5
  • 19
    • 0027431875 scopus 로고
    • Psychotic disorders diagnosed in adolescence. Outcome at age 30 years
    • Gillberg IC, Hellgren L, Gillberg C: Psychotic disorders diagnosed in adolescence. Outcome at age 30 years. J Child Psychol Psychiatry 34:1173-1185, 1993.
    • (1993) J Child Psychol Psychiatry , vol.34 , pp. 1173-1185
    • Gillberg, I.C.1    Hellgren, L.2    Gillberg, C.3
  • 21
    • 70350546566 scopus 로고    scopus 로고
    • A 6-week, randomized, double-blind, placebocontrolled study of the efficacy and safety of risperidone in adolescents with schizophrenia
    • Haas M, Unis AS, Armenteros J, Copenhaver MD, Quiroz JA, Kushner SF: A 6-week, randomized, double-blind, placebocontrolled study of the efficacy and safety of risperidone in adolescents with schizophrenia. J Child Adolesc Psychopharmacol 19:611-621, 2009.
    • (2009) J Child Adolesc Psychopharmacol , vol.19 , pp. 611-621
    • Haas, M.1    Unis, A.S.2    Armenteros, J.3    Copenhaver, M.D.4    Quiroz, J.A.5    Kushner, S.F.6
  • 25
    • 44049097402 scopus 로고    scopus 로고
    • Effectiveness of second generation antipsychotics: A systematic review of randomized trials
    • Johnsen E, Jrgensen HA: Effectiveness of second generation antipsychotics: A systematic review of randomized trials. BMC Psychiatry 8:31, 2008.
    • (2008) BMC Psychiatry , vol.8 , pp. 31
    • Johnsen, E.1    Jrgensen, H.A.2
  • 26
    • 0030954243 scopus 로고    scopus 로고
    • Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (k-sads-pl): Initial reliability and validity data
    • Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N: Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): Initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36:980-988, 1997.
    • (1997) J Am Acad Child Adolesc Psychiatry , vol.36 , pp. 980-988
    • Kaufman, J.1    Birmaher, B.2    Brent, D.3    Rao, U.4    Flynn, C.5    Moreci, P.6    Williamson, D.7    Ryan, N.8
  • 27
    • 0023606101 scopus 로고
    • The positive and negative syndrome scale (PANSS) for schizophrenia
    • Kay SR, Fiszbein A, Opler LA: The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261-276, 1987.
    • (1987) Schizophr Bull , vol.13 , pp. 261-276
    • Kay, S.R.1    Fiszbein, A.2    Opler, L.A.3
  • 28
    • 0020629612 scopus 로고
    • Initial anticholinergic prophylaxis for neuroleptic-induced extrapyramidal syndromes
    • Keepers GA, Clappison VJ, Casey DE: Initial anticholinergic prophylaxis for neuroleptic-induced extrapyramidal syndromes. Arch Gen Psychiatry 40:1113-1117, 1983.
    • (1983) Arch Gen Psychiatry , vol.40 , pp. 1113-1117
    • Keepers, G.A.1    Clappison, V.J.2    Casey, D.E.3
  • 29
    • 77954856854 scopus 로고    scopus 로고
    • Medical comorbidity in bipolar disorder: Relationship between illnesses of the endocrine/metabolic system and treatment outcome
    • Kemp DE, Gao K, Chan PK, Ganocy SJ, Findling RL, Calabrese JR: Medical comorbidity in bipolar disorder: relationship between illnesses of the endocrine/metabolic system and treatment outcome. Bipolar Disord 12:404-413, 2010.
    • (2010) Bipolar Disord , vol.12 , pp. 404-413
    • Kemp, D.E.1    Gao, K.2    Chan, P.K.3    Ganocy, S.J.4    Findling, R.L.5    Calabrese, J.R.6
  • 32
    • 0031722774 scopus 로고    scopus 로고
    • Open-label olanzapine treatment in five preadolescent children
    • Krishnamoorthy J, King BH: Open-label olanzapine treatment in five preadolescent children. J Child Adolesc Psychopharmacol 8:107-13, 1998.
    • (1998) J Child Adolesc Psychopharmacol , vol.8 , pp. 107-113
    • Krishnamoorthy, J.1    King, B.H.2
  • 37
    • 79953813625 scopus 로고    scopus 로고
    • Olanzapine approved for the acute treatment of schizophrenia or manic/mixed episodes associated with bipolar i disorder in adolescent patients
    • Maloney AE, Sikich L: Olanzapine approved for the acute treatment of schizophrenia or manic/mixed episodes associated with bipolar I disorder in adolescent patients. Neuropsychiatr Dis Treat 6:749-66, 2010.
    • (2010) Neuropsychiatr Dis Treat , vol.6 , pp. 749-766
    • Maloney, A.E.1    Sikich, L.2
  • 38
    • 79551559508 scopus 로고    scopus 로고
    • Management of schizophrenia in children and adolescents: Focus on pharmacotherapy
    • Masi G, Liboni F: Management of schizophrenia in children and adolescents: focus on pharmacotherapy. Drugs 71:179-208, 2011.
    • (2011) Drugs , vol.71 , pp. 179-208
    • Masi, G.1    Liboni, F.2
  • 41
    • 0037210111 scopus 로고    scopus 로고
    • Clozapine-induced weight gain predicts improvement in psychopathology
    • Meltzer HY, Perry E, Jayathilake K: Clozapine-induced weight gain predicts improvement in psychopathology. Schizophr Res 59:19-27, 2002.
    • (2002) Schizophr Res , vol.59 , pp. 19-27
    • Meltzer, H.Y.1    Perry, E.2    Jayathilake, K.3
  • 43
    • 74549159752 scopus 로고    scopus 로고
    • Prevalence of high body mass index in US children and adolescents 2007-2008
    • Ogden CL, Carroll MD, Curtin LR, Lamb MM, Flegal KM: Prevalence of high body mass index in US children and adolescents, 2007-2008.JAMA 303:242-249, 2010.
    • (2010) JAMA , vol.303 , pp. 242-249
    • Ogden, C.L.1    Carroll, M.D.2    Curtin, L.R.3    Lamb, M.M.4    Flegal, K.M.5
  • 44
    • 33744907790 scopus 로고    scopus 로고
    • National trends in the outpatient treatment of children and adolescents with antipsychotic drugs
    • Olfson M, Blanco C, Liu L, Moreno C, Laje G: National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. Arch Gen Psychiatry 63:679-685, 2006.
    • (2006) Arch Gen Psychiatry , vol.63 , pp. 679-685
    • Olfson, M.1    Blanco, C.2    Liu, L.3    Moreno, C.4    Laje, G.5
  • 45
    • 0019914121 scopus 로고
    • The brief psychiatric rating scale for children
    • Overall JE, Pfefferbaum B: The Brief Psychiatric Rating Scale for Children. Psychopharmacol Bull 18:10-16, 1982.
    • (1982) Psychopharmacol Bull , vol.18 , pp. 10-16
    • Overall, J.E.1    Pfefferbaum, B.2
  • 47
    • 0034806737 scopus 로고    scopus 로고
    • Inverse agonist actions of typical and atypical antipsychotic drugs at the human 5-hydroxytryptamine (2C) receptor
    • Rauser L, Savage JE, Meltzer HY, Roth BL: Inverse agonist actions of typical and atypical antipsychotic drugs at the human 5-hydroxytryptamine (2C) receptor. J Pharmacol Exp Ther 299:83-89, 2001.
    • (2001) J Pharmacol Exp Ther , vol.299 , pp. 83-89
    • Rauser, L.1    Savage, J.E.2    Meltzer, H.Y.3    Roth, B.L.4
  • 48
    • 82555177312 scopus 로고    scopus 로고
    • Atypical antipsychotic-induced weight gain: Insights into mechanisms of action
    • Roerig JL, Steffen KJ, Mitchell JE: Atypical antipsychotic-induced weight gain: Insights into mechanisms of action. CNS Drugs 25:1035-1059, 2011.
    • (2011) CNS Drugs , vol.25 , pp. 1035-1059
    • Roerig, J.L.1    Steffen, K.J.2    Mitchell, J.E.3
  • 49
    • 33750617060 scopus 로고    scopus 로고
    • High rates of comorbidity are found in childhood-onset schizophrenia
    • Ross RG, Heinlein S, Tregellas H: High rates of comorbidity are found in childhood-onset schizophrenia. Schizophr Res 88:90-95, 2006.
    • (2006) Schizophr Res , vol.88 , pp. 90-95
    • Ross, R.G.1    Heinlein, S.2    Tregellas, H.3
  • 50
    • 0142025523 scopus 로고    scopus 로고
    • A 1-year open-label trial of olanzapine in school-age children with schizophrenia
    • Ross RG, Novins D, Farley GK, Adler LE: A 1-year open-label trial of olanzapine in school-age children with schizophrenia. J Child Adolesc Psychopharmacol 13:301-309, 2003.
    • (2003) J Child Adolesc Psychopharmacol , vol.13 , pp. 301-309
    • Ross, R.G.1    Novins, D.2    Farley, G.K.3    Adler, L.E.4
  • 52
    • 81855204965 scopus 로고    scopus 로고
    • A randomized, Double-blind study of paliperidone extended-release in treatment of acute schizophrenia in adolescents
    • Singh J, Robb A, Vijapurkar U, Nuamah I, Hough D: A randomized, double-blind study of paliperidone extended-release in treatment of acute schizophrenia in adolescents. Biol Psychiatry 70:1179-1187, 2011.
    • (2011) Biol Psychiatry , vol.70 , pp. 1179-1187
    • Singh, J.1    Robb, A.2    Vijapurkar, U.3    Nuamah, I.4    Hough, D.5
  • 53
    • 0014876487 scopus 로고
    • Weight as a correlate of clinical response to psychotropic drugs
    • Singh MM, De Dios LV, Klein NS: Weight as a correlate of clinical response to psychotropic drugs. Psychosomatics 11:562-570, 1970.
    • (1970) Psychosomatics , vol.11 , pp. 562-570
    • Singh, M.M.1    De Dios, L.V.2    Klein, N.S.3
  • 54
    • 80052490081 scopus 로고    scopus 로고
    • The schizophrenia trials network: A randomized trial examining the effectiveness of switching from olanzapine, Quetiapine, or risperidone to aripiprazole to reduce metabolic risk: Comparison of antipsychotics for metabolic problems (camp)
    • Stroup TS, McEvoy JP, Ring KD, Hamer RH, Lavange LM, Swartz MS, Rosenheck RA, Perkins DO, Nussbaum AM, Lieberman JA, the Schizophrenia Trials Network: A randomized trial examining the effectiveness of switching from olanzapine, quetiapine, or risperidone to aripiprazole to reduce metabolic risk: Comparison of Antipsychotics for Metabolic Problems (CAMP). Am J Psychiatry 168:947-956, 2011.
    • (2011) Am J Psychiatry , vol.168 , pp. 947-956
    • Stroup, T.S.1    McEvoy, J.P.2    Ring, K.D.3    Hamer, R.H.4    Lavange, L.M.5    Swartz, M.S.6    Rosenheck, R.A.7    Perkins, D.O.8    Nussbaum, A.M.9    Lieberman, J.A.10
  • 55
    • 0034782477 scopus 로고    scopus 로고
    • Prevalence of obesity in adolescent and young adult patients with and without schizophrenia and in relationship to antipsychotic medication
    • Theisen FM, Linden A, Geller F, Schafer H, Martin M, Remschmidt H, Hebebrand J: Prevalence of obesity in adolescent and young adult patients with and without schizophrenia and in relationship to antipsychotic medication. J Psychiatr Res 35:339-345, 2001.
    • (2001) J Psychiatr Res , vol.35 , pp. 339-345
    • Theisen, F.M.1    Linden, A.2    Geller, F.3    Schafer, H.4    Martin, M.5    Remschmidt, H.6    Hebebrand, J.7
  • 56
    • 33745395221 scopus 로고    scopus 로고
    • Prevalence and clinical correlates of medical comorbidities in patients with bipolar i disorder: Analysis of acute phase data from a randomized controlled trial
    • Thompson WK, Kupfer DJ, Fagiolini A, Scott JA, Frank E: Prevalence and clinical correlates of medical comorbidities in patients with bipolar I disorder: Analysis of acute phase data from a randomized controlled trial. J Clin Psychiatry 67: 783-788, 2006.
    • (2006) J Clin Psychiatry , vol.67 , pp. 783-788
    • Thompson, W.K.1    Kupfer, D.J.2    Fagiolini, A.3    Scott, J.A.4    Frank, E.5
  • 58
    • 0028051552 scopus 로고
    • Clinical features and outcome of child and adolescent schizophrenia
    • Werry JS, McClellan JM, Andrews LK, Ham M: Clinical features and outcome of child and adolescent schizophrenia. Schizophr Bull 20:619-630, 1994.
    • (1994) Schizophr Bull , vol.20 , pp. 619-630
    • Werry, J.S.1    McClellan, J.M.2    Andrews, L.K.3    Ham, M.4
  • 59
    • 0022656140 scopus 로고
    • The Overt Aggression Scale for the objective rating of verbal and physical aggression
    • Yudofsky SC, Silver JM, Jackson W, Endicott J, Williams D: The Overt Aggression Scale for the objective rating of verbal and physical aggression. Am J Psychiatry 143:35-3n9, 1986.
    • (1986) Am J Psychiatry , vol.143 , pp. 35-39
    • Yudofsky, S.C.1    Silver, J.M.2    Jackson, W.3    Endicott, J.4    Williams, D.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.